JP2017536454A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536454A5
JP2017536454A5 JP2017526910A JP2017526910A JP2017536454A5 JP 2017536454 A5 JP2017536454 A5 JP 2017536454A5 JP 2017526910 A JP2017526910 A JP 2017526910A JP 2017526910 A JP2017526910 A JP 2017526910A JP 2017536454 A5 JP2017536454 A5 JP 2017536454A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
skin
composition according
polypeptide
heparan sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017526910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536454A (ja
JP6709217B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2015/050464 external-priority patent/WO2016080916A1/en
Publication of JP2017536454A publication Critical patent/JP2017536454A/ja
Publication of JP2017536454A5 publication Critical patent/JP2017536454A5/ja
Application granted granted Critical
Publication of JP6709217B2 publication Critical patent/JP6709217B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017526910A 2014-11-19 2015-11-19 皮膚の修復および／または再生において使用するためのヘパラン硫酸 Expired - Fee Related JP6709217B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201408007P 2014-11-19
SG10201408007P 2014-11-19
PCT/SG2015/050464 WO2016080916A1 (en) 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin

Publications (3)

Publication Number Publication Date
JP2017536454A JP2017536454A (ja) 2017-12-07
JP2017536454A5 true JP2017536454A5 (OSRAM) 2018-12-27
JP6709217B2 JP6709217B2 (ja) 2020-06-10

Family

ID=56014304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017526910A Expired - Fee Related JP6709217B2 (ja) 2014-11-19 2015-11-19 皮膚の修復および／または再生において使用するためのヘパラン硫酸

Country Status (6)

Country Link
US (1) US10471091B2 (OSRAM)
EP (1) EP3220922B1 (OSRAM)
JP (1) JP6709217B2 (OSRAM)
CN (1) CN107249599A (OSRAM)
SG (1) SG11201704085QA (OSRAM)
WO (1) WO2016080916A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014185858A1 (en) 2013-05-16 2014-11-20 Agency For Science, Technology And Research Heparan sulphates
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
EP3349668B1 (en) 2015-09-15 2023-03-29 Savage Medical, Inc. Devices for anchoring a sheath in a tissue cavity
JP6927985B2 (ja) 2016-01-18 2021-09-01 フィッシャー アンド ペイケル ヘルスケア リミテッド 呼吸ガスの加湿
JP6815782B2 (ja) * 2016-07-29 2021-01-20 小林製薬株式会社 α−ＳＭＡ産生抑制剤
CN106544318A (zh) * 2016-11-28 2017-03-29 广东万海细胞生物科技有限公司 促进脐带间充质干细胞定向分化为脂肪细胞的方法
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
JPWO2024080183A1 (OSRAM) * 2022-10-14 2024-04-18

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
JPH0240399A (ja) 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
GB9017008D0 (en) 1990-08-02 1990-09-19 Erba Carlo Spa Process for the enzymatic preparation of basic fibroblast growth factor
MX9201801A (es) 1991-04-16 1992-10-30 Seikagaku Kogyo Co Ltd Oligosacarido que tiene afinidad para el factor de desarrollo del fibroplasto y procedimiento para producirlo.
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
JP4768936B2 (ja) * 2000-08-07 2011-09-07 生化学工業株式会社 硫酸基を有するオリゴ糖
FR2812551B1 (fr) * 2000-08-07 2003-03-28 Virsol Forme pharmaceutique comprenant un materiau support a base de methylidene malonate et un facteur de regulation cellulaire
US20060183712A1 (en) 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
WO2010011185A1 (en) 2008-07-21 2010-01-28 Agency For Science, Technology And Research Stem cells obtained through in vitro culture with heparan sulfate
US9498494B2 (en) * 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB2463474B (en) 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
HRP20140862T1 (hr) 2008-11-20 2014-11-07 Laboratori Derivati Organici S.P.A. Uporaba heparan sulfata u kozmetiäśkim i dermatološkim pripravcima
FR2940610B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
SG188756A1 (en) 2011-09-16 2013-04-30 Agency Science Tech & Res Glycosaminoglycans
WO2014185858A1 (en) 2013-05-16 2014-11-20 Agency For Science, Technology And Research Heparan sulphates
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate

Similar Documents

Publication Publication Date Title
JP2017536454A5 (OSRAM)
EP3432897A2 (en) Use of umbilical cord blood derived exosomes for tissue repair
US8110655B2 (en) Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor
NZ223520A (en) Wound healing pharmaceutical formulation comprising insulin-like growth factor-ii (igf-ii)
CN105491982A (zh) 用于增强透皮递送的肽
JP3236916B2 (ja) 細胞及び組織を再生させる活性を有する薬剤、該薬剤を含有する安定化された組成物及びそれらの治療的、外科的及び美容学的用途
JP2016521746A5 (OSRAM)
US20240261377A1 (en) Use of clostridium histolyticum protease mixture in promoting wound healing
TR201809034T4 (tr) Biyo-rejeneratif, restoratif ve ötrofik aktiviteye sahip bileşim.
US8207118B2 (en) Skin wound healing compositions and methods of use thereof
US7993665B2 (en) Wound healing agent and composition
JP5342455B2 (ja) 細胞調整及び免疫調整のための短い生物活性ペプチド
Kaiser et al. Role of extracellular vesicles in stem cell therapy
KR101752286B1 (ko) 피부 미용기 및 이의 용도
EP3334441A1 (en) Compositions derived from cohn fraction paste and use thereof
CN104490760A (zh) 辣椒碱-胶原蛋白海绵的制备方法及其应用
CN113332297B (zh) 化合物25-hl在制备治疗皮肤损伤的药物中的应用
US20220096709A1 (en) Wound healing therapeutic hydrogels
KR101820519B1 (ko) 설글리코타이드의 피부 상처 치유 촉진 용도, 및 이를 포함하는 외용제 조성물
US20220031715A1 (en) Compositions and methods for enhancing wound healing
Li et al. The potential application of exosomes as therapeutic agents, carriers, and biomarkers in skin diseases
RU2153352C1 (ru) Фармацевтическая композиция, обладающая ранозаживляющим и противовоспалительным действием
EP1955704A1 (en) Wound healing agent and composition
US20080194478A1 (en) Wound healing agent and composition
Mori et al. 1471 A new proposal for skin wound healing: The combination of HMGB1 B-Box and non-equilibrium atmospheric pressure plasma